News Image

On Friday, there are stocks with unusual volume. Let's take a look.

By Mill Chart

Last update: Mar 15, 2024

Volume analysis on 2024-03-15: stocks with an unusual volume in today's session.

Top unusual volume stocks

TickerChangeComment
LSF20.86%Today, LAIRD SUPERFOOD INC (NYSEARCA:LSF) stands out with a high volume of 1.44M shares. The market is favoring NYSEARCA:LSF today, as its share price records a notable increase of 20.86%. The average volume measured over 50 days is 478.46K, so this is 200.0% above the average volume.
JFBR1.61%JEFFS BRANDS LTD (NASDAQ:JFBR) has an unusual volume of 819.48K shares. Investors in NASDAQ:JFBR are enjoying a price surge of 1.61% today, indicating bullish market sentiment. In comparison to the average daily volume of the last 50 days, the current volume is 124.0% above. This suggests a notable change in trading activity.
BCAN-7.39%50.57M shares of BYND CANNASOFT ENTERPRISES (NASDAQ:BCAN) exchanged hands today. Leading to a price decrease of 7.39%. The current trading volume is 786.0% above the average 50-day volume. This indicates a significant deviation from the average trading activity.
GRPH-5.78%597.31K shares of GRAPHITE BIO INC (NASDAQ:GRPH) have been traded so far today. The current market conditions have led to a price decrease of 5.78% for NASDAQ:GRPH. The average volume over the last 50 days is 260.99K, making today's volume 129.0% above the average. This signifies a notable change in market participation.
VERI35.51%The stock of VERITONE INC (NASDAQ:VERI) has caught attention with a significant volume of 10.49M shares today. The price of NASDAQ:VERI has increased by 35.51%, indicating upward momentum in the market. With an average volume of 1.33M over the past 50 days, the current volume is 691.0% above the average. This deviation signals a potential shift in market dynamics.
IMRX-28.79%The trading volume of IMMUNEERING CORP - CLASS A (NASDAQ:IMRX) today is 2.09M shares, which is considered unusual. Shares are falling by 28.79%. Compared to the average daily volume of the past 50 days, the current volume is 1.0K% above, suggesting an unusual level of trading activity. A press release (Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors) was released yesterday.
LICY7.47%LI-CYCLE HOLDINGS CORP's (NYSE:LICY) traded a high volume of 7.12M shares. The market is favoring NYSE:LICY today, as its share price records a notable increase of 7.47%. The current trading volume is 25.82% above the average 50-day volume. This indicates a significant deviation from the average trading activity.
TCON-14.34%The stock of TRACON PHARMACEUTICALS INC (NASDAQ:TCON) has caught attention with a significant volume of 5.17M shares today. The price decline of 14.34% reflects a downward movement in NASDAQ:TCON shares. Compared to the average daily volume of the past 50 days, the current volume is 103.0% above, suggesting an unusual level of trading activity.
SPRB6.17%5.71M shares of SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) have been traded so far today. The share price increased by 6.17%. This is 509.0% above the average daily volume of the last 50 days. Two days ago the company had a press release: Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates.
CYTH12.26%CYCLO THERAPEUTICS INC (NASDAQ:CYTH) has an unusual volume of 168.08K shares today. Shares are rising by 12.26%. The average daily volume over the past 50 days is 105.15K. Hence, the current volume is 59.85% above the average volume, indicating a deviation from the usual trading pattern. A press release (Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results) was released two days ago.

Our unusual volume stocks screener will show you the full list.

Back

CYCLO THERAPEUTICS INC

NASDAQ:CYTH (4/24/2024, 9:19:55 AM)

1.22

+0.01 (+0.83%)

CYTH News

News Imagea month ago - BusinessInsiderCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cyclo Therapeutics (NASDAQ:CYTH) just reported results for the fourth quarter o...

News Imagea month ago - InvestorPlaceCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023

Cyclo Therapeutics just reported results for the fourth quarter of 2023.

News Imagea month ago - Cyclo Therapeutics, Inc.Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
News Imagea month ago - Cyclo Therapeutics, Inc.Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease
News Imagea month ago - Rafael Holdings, Inc.Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
News Image3 months ago - Cyclo Therapeutics, Inc.Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
News Image4 months ago - Cyclo Therapeutics, Inc.Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
News Image4 months ago - Cyclo Therapeutics, Inc.Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
News Image4 months ago - Rafael Holdings, Inc.Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

Company remains focused on generating shareholder value by advancing our portfolio and identifying attractive opportunities for strategic investments

News Image5 months ago - Cyclo Therapeutics, Inc.Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024
News Image5 months ago - Cyclo Therapeutics, Inc.Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
News Image6 months ago - Rafael Holdings, Inc.Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

Company positions itself to generate value for its stockholders by curtailing expenses while increasing investment in strategic opportunities

CYTH Links
Follow us for more